These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31802229)

  • 1. IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.
    Granai M; Amato T; Di Napoli A; Santi R; Vergoni F; Di Stefano G; Mancini V; Kovalchuk S; Cencini E; Carta AG; Aversa S; Ziepert M; Cevenini G; Lazzi S; Leoncini L; Bellan C
    Virchows Arch; 2020 Jul; 477(1):143-150. PubMed ID: 31802229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of VH genes in marginal zone lymphoma reveals marked heterogeneity between splenic and nodal tumors and suggests the existence of clonal selection.
    Traverse-Glehen A; Davi F; Ben Simon E; Callet-Bauchu E; Felman P; Baseggio L; Gazzo S; Thieblemont C; Charlot C; Coiffier B; Berger F; Salles G
    Haematologica; 2005 Apr; 90(4):470-8. PubMed ID: 15820942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetics features and genomic lesions in splenic marginal zone lymphoma.
    Rinaldi A; Forconi F; Arcaini L; Mian M; Sozzi E; Zibellini S; Baldini L; Franceschetti S; Gaidano G; Marasca R; Mollejo M; Piris MA; Tucci A; Facchetti F; Bhagat G; Favera RD; Rancoita PM; Zucca E; Kwee I; Bertoni F
    Br J Haematol; 2010 Dec; 151(5):435-9. PubMed ID: 21113978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
    Bikos V; Karypidou M; Stalika E; Baliakas P; Xochelli A; Sutton LA; Papadopoulos G; Agathangelidis A; Papadopoulou E; Davis Z; Algara P; Kanellis G; Traverse-Glehen A; Mollejo M; Anagnostopoulos A; Ponzoni M; Gonzalez D; Pospisilova S; Matutes E; Piris MA; Papadaki T; Ghia P; Rosenquist R; Oscier D; Darzentas N; Tzovaras D; Belessi C; Hadzidimitriou A; Stamatopoulos K
    Clin Cancer Res; 2016 Apr; 22(8):2032-40. PubMed ID: 26647217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.
    Arcaini L; Zibellini S; Passamonti F; Rattotti S; Lucioni M; Invernizzi R; Merli M; Rizzi S; Boveri E; Rumi E; Astori C; Picone C; Varettoni M; Pascutto C; Paulli M; Lazzarino M
    Blood Cells Mol Dis; 2009; 42(3):286-91. PubMed ID: 19250848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas.
    Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J
    Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics of nodal marginal zone lymphoma.
    Spina V; Khiabanian H; Messina M; Monti S; Cascione L; Bruscaggin A; Spaccarotella E; Holmes AB; Arcaini L; Lucioni M; Tabbò F; Zairis S; Diop F; Cerri M; Chiaretti S; Marasca R; Ponzoni M; Deaglio S; Ramponi A; Tiacci E; Pasqualucci L; Paulli M; Falini B; Inghirami G; Bertoni F; Foà R; Rabadan R; Gaidano G; Rossi D
    Blood; 2016 Sep; 128(10):1362-73. PubMed ID: 27335277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic marginal zone lymphomas appear to originate from different B cell types.
    Bahler DW; Pindzola JA; Swerdlow SH
    Am J Pathol; 2002 Jul; 161(1):81-8. PubMed ID: 12107092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
    Bikos V; Darzentas N; Hadzidimitriou A; Davis Z; Hockley S; Traverse-Glehen A; Algara P; Santoro A; Gonzalez D; Mollejo M; Dagklis A; Gangemi F; Bosler DS; Bourikas G; Anagnostopoulos A; Tsaftaris A; Iannitto E; Ponzoni M; Felman P; Berger F; Belessi C; Ghia P; Papadaki T; Dogan A; Degano M; Matutes E; Piris MA; Oscier D; Stamatopoulos K
    Leukemia; 2012 Jul; 26(7):1638-46. PubMed ID: 22222599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations.
    Tierens A; Delabie J; Malecka A; Wang J; Gruszka-Westwood A; Catovsky D; Matutes E
    Am J Pathol; 2003 Feb; 162(2):681-9. PubMed ID: 12547726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
    Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
    Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma.
    Marasca R; Vaccari P; Luppi M; Zucchini P; Castelli I; Barozzi P; Cuoghi A; Torelli G
    Am J Pathol; 2001 Jul; 159(1):253-61. PubMed ID: 11438472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma.
    Stamatopoulos K; Belessi C; Papadaki T; Kalagiakou E; Stavroyianni N; Douka V; Afendaki S; Saloum R; Parasi A; Anagnostou D; Laoutaris N; Fassas A; Anagnostopoulos A
    Mol Med; 2004; 10(7-12):89-95. PubMed ID: 15706403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic marginal-zone lymphoma: one or more entities? A histologic, immunohistochemical, and molecular study of 42 cases.
    Papadaki T; Stamatopoulos K; Belessi C; Pouliou E; Parasi A; Douka V; Laoutaris N; Fassas A; Anagnostopoulos A; Anagnostou D
    Am J Surg Pathol; 2007 Mar; 31(3):438-46. PubMed ID: 17325486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders.
    Brisou G; Verney A; Wenner T; Baseggio L; Felman P; Callet-Bauchu E; Coiffier B; Berger F; Salles G; Traverse-Glehen A
    Haematologica; 2014 Oct; 99(10):e197-8. PubMed ID: 24997147
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation.
    Dunn-Walters DK; Boursier L; Spencer J; Isaacson PG
    Hum Pathol; 1998 Jun; 29(6):585-93. PubMed ID: 9635678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodal marginal zone B-cell lymphomas may arise from different subsets of marginal zone B lymphocytes.
    Conconi A; Bertoni F; Pedrinis E; Motta T; Roggero E; Luminari S; Capella C; Bonato M; Cavalli F; Zucca E
    Blood; 2001 Aug; 98(3):781-6. PubMed ID: 11468179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukemia are composed of memory B lymphocytes.
    Miranda RN; Cousar JB; Hammer RD; Collins RD; Vnencak-Jones CL
    Hum Pathol; 1999 Mar; 30(3):306-12. PubMed ID: 10088550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia.
    Stamatopoulos B; Timbs A; Bruce D; Smith T; Clifford R; Robbe P; Burns A; Vavoulis DV; Lopez L; Antoniou P; Mason J; Dreau H; Schuh A
    Leukemia; 2017 Apr; 31(4):837-845. PubMed ID: 27795555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gene is known by the company it keeps: enrichment of TNFAIP3 gene aberrations in MALT lymphomas expressing IGHV4-34 antigen receptors.
    Agathangelidis A; Xochelli A; Stamatopoulos K
    J Pathol; 2017 Dec; 243(4):403-406. PubMed ID: 28892161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.